135 related articles for article (PubMed ID: 21692046)
1. Do patients consider preoperative chemoradiation for primary rectal cancer worthwhile?
Kennedy ED; Schmocker S; Victor C; Baxter NN; Kim J; Brierley J; McLeod RS
Cancer; 2011 Jul; 117(13):2853-62. PubMed ID: 21692046
[TBL] [Abstract][Full Text] [Related]
2. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
3. The clinical significance of the circumferential resection margin following preoperative pelvic chemo-radiotherapy in rectal cancer: why we need a common language.
Glynne-Jones R; Mawdsley S; Novell JR
Colorectal Dis; 2006 Nov; 8(9):800-7. PubMed ID: 17032329
[TBL] [Abstract][Full Text] [Related]
4. [Results of the local excision of rectal cancer after high-dose radiotherapy associated or not to chemotherapy].
Masoni L; Marks G; Petruzziello L; Marks J; Montori J; Aguzzi D; de Anna L; La Torre F; Montori A
G Chir; 1997 Oct; 18(10):622-9. PubMed ID: 9479976
[TBL] [Abstract][Full Text] [Related]
5. Patient profile and treatment outcome of rectal cancer patients treated with multimodality therapy at a regional cancer center.
Deo S; Kumar S; Shukla NK; Kar M; Mohanti BK; Sharma A; Raina V; Rath GK
Indian J Cancer; 2004; 41(3):120-4. PubMed ID: 15472410
[TBL] [Abstract][Full Text] [Related]
6. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy].
Thomschke D; Kyau-Ummen B; Halbfass HJ
Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499
[TBL] [Abstract][Full Text] [Related]
7. [Preoperative chemoradiation therapy for lower rectal cancer].
Murotani M; Tsujinaka T; Takami M; Takada T; Kitada M; Tsukahara Y; Shibata T; Niinobu T; Iihara K; Tsukamoto F; Ogawa M; Kimura M; Nose T
Gan To Kagaku Ryoho; 1996 Sep; 23(11):1482-5. PubMed ID: 8854786
[TBL] [Abstract][Full Text] [Related]
8. [Adjuvant therapy of rectal cancer].
Bouaouina N; Boussen H
Tunis Med; 2003 Feb; 81(2):73-9. PubMed ID: 12708171
[TBL] [Abstract][Full Text] [Related]
9. Local recurrence of rectal cancer following preoperative irradiation.
Illényi L; Grexa E; Gecser G; Kött I
Acta Chir Hung; 1994; 34(3-4):333-47. PubMed ID: 7618387
[TBL] [Abstract][Full Text] [Related]
10. Multidisciplinary treatment of resectable rectal cancer.
Ayala DN; Russo SM; Blackstock AW
Expert Rev Gastroenterol Hepatol; 2009 Aug; 3(4):383-94. PubMed ID: 19673625
[TBL] [Abstract][Full Text] [Related]
11. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients.
Bonnen M; Crane C; Vauthey JN; Skibber J; Delclos ME; Rodriguez-Bigas M; Hoff PM; Lin E; Eng C; Wong A; Janjan NA; Feig BW
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1098-105. PubMed ID: 15519780
[TBL] [Abstract][Full Text] [Related]
12. [Rectal cancer: treatment and results].
Luna Pérez P
Rev Invest Clin; 2001; 53(1):65-76. PubMed ID: 11332053
[No Abstract] [Full Text] [Related]
13. Patient's preferences for adjuvant postoperative chemoradiation therapy in rectal cancer.
Couture J; Chan R; Bouharaoui F
Dis Colon Rectum; 2005 Nov; 48(11):2055-60. PubMed ID: 16228832
[TBL] [Abstract][Full Text] [Related]
14. Will we ever succeed in resolving the adjuvant treatment dilemma in rectal cancer?
Petrelli NJ
J Surg Oncol; 2003 Feb; 82(2):79-83. PubMed ID: 12561061
[No Abstract] [Full Text] [Related]
15. [Choice of treatment in rectal cancer. Consensus Conference, Chamber of Commerce and Industry, Paris, December 1-2, 1994].
Ann Gastroenterol Hepatol (Paris); 1995 Sep; 31(4):226-30, 233-6. PubMed ID: 7486820
[No Abstract] [Full Text] [Related]
16. Preoperative chemoradiation therapy for low rectal cancer. Impact on downstaging and sphincter-saving operations.
Habr-Gama A; Perez RO; Kiss DR; Rawet V; Scanavini A; Santinho PM; Nadalin W
Hepatogastroenterology; 2004; 51(60):1703-7. PubMed ID: 15532809
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy of postoperative chemoradiation for stage III low rectal cancer].
Zhou Y; Hua Y; Wang T; Chen S; Wang FW; Wang WZ; Zhang XP
Zhonghua Wei Chang Wai Ke Za Zhi; 2010 Oct; 13(10):748-50. PubMed ID: 20972904
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemoradiation versus hyperfractionated accelerated radiotherapy in locally advanced rectal cancer.
Ceelen W; Boterberg T; Pattyn P; van Eijkeren M; Gillardin JM; Demetter P; Smeets P; Van Damme N; Monsaert E; Peeters M
Ann Surg Oncol; 2007 Feb; 14(2):424-31. PubMed ID: 17096057
[TBL] [Abstract][Full Text] [Related]
19. Serum CEA as a predictor for the response to preoperative chemoradiation in rectal cancer.
Park YA; Sohn SK; Seong J; Baik SH; Lee KY; Kim NK; Cho CW
J Surg Oncol; 2006 Feb; 93(2):145-50. PubMed ID: 16425302
[TBL] [Abstract][Full Text] [Related]
20. Effect of adjuvant radiotherapy on local recurrence in stage II rectal cancer.
Park IJ; Kim HC; Yu CS; Kim TW; Jang SJ; Kim JC
Ann Surg Oncol; 2008 Feb; 15(2):519-25. PubMed ID: 17960464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
